相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion
Karim Sacre et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
Victoria Furer et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
Jing He et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment
Christina Adamichou et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren's syndrome highlight T cell-initiated autoimmunity
Yukai Wang et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach
John G. Hanly et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention
Myrto Kostopoulou et al.
CURRENT VASCULAR PHARMACOLOGY (2020)
Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the 'Attikon' cohort
D. Nikolopoulos et al.
LUPUS (2020)
A Successful Trial for Lupus - How Good Is Good Enough?
Jane E. Salmon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Eric F. Morand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Population-based studies in systemic lupus erythematosus: immune thrombocytopenic purpura or 'blood-dominant' lupus?
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study
Fang-Xiao Zhu et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus
Konstantinos Tselios et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis
Gabriella Moroni et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Richard Furie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
AURORA PHASE 3 STUDY DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN)
C. Arriens et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease
Dionysis S. Nikolopoulos et al.
LUPUS SCIENCE & MEDICINE (2020)
Two distinct clinical phenotypes of pulmonary arterial hypertension secondary to systemic lupus erythematosus
Fangfang Sun et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero
Johannes Mofors et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database
Laurent Arnaud et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes
Michelle Barraclough et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial
Chi Chiu Mok et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Martin Aringer et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Malignancies in systemic lupus erythematosus: an update
Alexandra Ladouceur et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Update on the pathogenesis of central nervous system lupus
Dionysis Nikolopoulos et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Current challenges in the development of new treatments for lupus
Maria Dall'Era et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Inflammation in SLE-PAH: good news or not?
Junyan Qian et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity
Diogo Jesus et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort
Arielle Mendel et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis
Murray B. Urowitz et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
Brad H. Rovin et al.
KIDNEY INTERNATIONAL (2019)
Disease course patterns in systemic lupus erythematosus
K. Tselios et al.
LUPUS (2019)
Antimalarial-induced cardiomyopathy: a systematic review of the literature
K. Tselios et al.
LUPUS (2018)
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis
Gabriella Moroni et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE
David S. Pisetsky et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies
Mimi Y. Kim et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
Daniel J. Wallace et al.
LANCET (2018)
Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort
Constance Jensina Ulff-Moller et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus
Lea Winau et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography
Thilo Burkard et al.
PLOS ONE (2018)
2008-2018: a decade of recommendations for systemic lupus erythematosus
Dimitrios T. Boumpas et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus
Efrosini Papadaki et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission
Margherita Zen et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses' Health Study cohorts
Medha Barbhaiya et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
L. Andreoli et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
Ronald van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Distinguishing infections vs flares in patients with systemic lupus erythematosus
Fabio E. Ospina et al.
RHEUMATOLOGY (2017)
Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement
Danielle Cohen et al.
RHEUMATOLOGY (2017)
Multitarget Therapy for Maintenance Treatment of Lupus Nephritis
Haitao Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece
Irini Gergianaki et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial
Josep Ordi-Ros et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Stroke in systemic lupus erythematosus: a Swedish population-based cohort study
Elizabeth V. Arkema et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients
Pierre-Edouard Gavand et al.
AUTOIMMUNITY REVIEWS (2017)
Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis
Emilie C. Rijnink et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study
Chao-Han Lai et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
Kate Franklyn et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Clinical and financial burden of active lupus in Greece: a nationwide study
G. Bertsias et al.
LUPUS (2016)
The global burden of SLE: prevalence, health disparities and socioeconomic impact
Erin E. Carter et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Predictors of Pregnancy Outcomes in Patients With Lupus A Cohort Study
Jill P. Buyon et al.
ANNALS OF INTERNAL MEDICINE (2015)
Multitarget Therapy for Induction Treatment of Lupus Nephritis A Randomized Trial
Zhihong Liu et al.
ANNALS OF INTERNAL MEDICINE (2015)
Prolonged remission in Caucasian patients with SLE: prevalence and outcomes
Margherita Zen et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research
Jamal Mikdashi et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families
Chang-Fu Kuo et al.
JAMA INTERNAL MEDICINE (2015)
Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study
Seoyoung C. Kim et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus
Johanna T. Gustafsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus
Alessandra Bortoluzzi et al.
RHEUMATOLOGY (2015)
Annual direct medical cost of active systemic lupus erythematosus in five European countries
Andrea Doria et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Lymphoma risk in systemic lupus: effects of disease activity versus treatment
Sasha Bernatsky et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Syndromes of Thrombotic Microangiopathy
James N. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Diagnostic criteria for systemic lupus erythematosus: has the time come?
George K. Bertsias et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade
George K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics
G. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
The history of lupus erythematosus
Ravi K. Mallavarapu et al.
SOUTHERN MEDICAL JOURNAL (2007)
Combined oral contraceptives in women with systemic lupus erythematosus
M Petri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A trial of contraceptive methods in women with systemic lupus erythematosus
J Sánchez-Guerrero et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial
JP Buyon et al.
ANNALS OF INTERNAL MEDICINE (2005)
分享论文
